We are live on ! Find out more
ACM

Arlington Capital Management Portfolio holdings

AUM $161M
1-Year Est. Return 38.38%
This Fund
S&P 500
This Quarter Est. Return
+12.4%
1 Year Est. Return
+38.38%
3 Year Est. Return
+153.55%
5 Year Est. Return
+294.8%
10 Year Est. Return
+509.37%
AUM
$118M
AUM Growth
Cap. Flow
+$112M
Cap. Flow %
94.99%
Top 10 Hldgs %
76.1%
Holding
31
New
31
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 11.83%
2 Healthcare 10.63%
3 Industrials 9.07%
4 Communication Services 1.54%
5 Real Estate 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBB icon
1
iShares Biotechnology ETF
IBB
$9.45B
$15.1M 12.79%
+149,508
New +$14.5M
IYT icon
2
iShares US Transportation ETF
IYT
$2.28B
$12.7M 10.74%
+309,468
New +$12.2M
IHF icon
3
iShares US Healthcare Providers ETF
IHF
$1.22B
$12.1M 10.22%
+510,195
New +$11.5M
INDY icon
4
iShares S&P India Nifty 50 Index Fund
INDY
$558M
$11.6M 9.8%
+387,192
New +$11.8M
ASHR icon
5
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.53B
$7.76M 6.57%
+208,635
New +$6.1M
LUV icon
6
Southwest Airlines
LUV
$21.7B
$7.58M 6.41%
+179,105
New +$6.69M
BBWI icon
7
Bath & Body Works
BBWI
$3.97B
$7.42M 6.28%
+106,112
New +$6.55M
ULTA icon
8
Ulta Beauty
ULTA
$21.8B
$6.55M 5.55%
+51,257
New +$6.28M
FXI icon
9
iShares China Large-Cap ETF
FXI
$4.32B
$6.11M 5.17%
+146,741
New +$5.8M
VRTX icon
10
Vertex Pharmaceuticals
VRTX
$123B
$3.04M 2.57%
+25,544
New +$2.88M
CELG
11
DELISTED
Celgene Corp
CELG
$2.89M 2.44%
+25,828
New +$2.72M
XPO icon
12
XPO
XPO
$23.4B
$2.78M 2.35%
+196,528
New +$2.59M
AMGN icon
13
Amgen
AMGN
$209B
$2.7M 2.28%
+16,937
New +$2.64M
MDVN
14
DELISTED
MEDIVATION, INC.
MDVN
$2.61M 2.21%
+52,354
New +$2.72M
BMRN icon
15
BioMarin Pharmaceuticals
BMRN
$11.9B
$2.39M 2.02%
+26,439
New +$2.2M
AMJ
16
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$2.13M 1.81%
+46,469
New +$2.27M
MPT
17
Medical Properties Trust
MPT
$2.84B
$1.47M 1.24%
+106,752
New +$1.43M
LUMN icon
18
Lumen
LUMN
$6.43B
$1.36M 1.15%
+34,405
New +$1.38M
FLG
19
Flagstar Bank National Association
FLG
$5.87B
$1.33M 1.12%
+27,666
New +$1.3M
HTS
20
DELISTED
HATTERAS FINANCIAL CORP
HTS
$1.31M 1.11%
+71,095
New +$1.34M
REM icon
21
iShares Mortgage Real Estate ETF
REM
$549M
$1.31M 1.11%
+27,884
New +$1.37M
REGN icon
22
Regeneron Pharmaceuticals
REGN
$72.9B
$1.27M 1.07%
+3,086
New +$1.21M
HPF
23
John Hancock Preferred Income Fund II
HPF
$340M
$983K 0.83%
+48,325
New +$982K
BAC.PRL icon
24
Bank of America Series L
BAC.PRL
$3.93B
$949K 0.8%
+817
New +$947K
EMB icon
25
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$811K 0.69%
+7,392
New +$832K

Similar funds

Arlington Capital Management's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Arlington Capital Management, which disclosed 31 positions worth $118M. Its ten largest holdings account for 76% of the portfolio.

Its largest position is iShares Biotechnology ETF: 149,508 shares worth $15.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, followed by Healthcare and Industrials.

  • Arlington Capital Management's largest Q4 2014 buy was iShares Biotechnology ETF: 149,508 shares worth $15.1M.
  • Arlington Capital Management's ten largest holdings make up 76% of its $118M portfolio in Q4 2014.
  • Arlington Capital Management disclosed 31 positions in Q4 2014, its first 13F filing on record.

Based on Arlington Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.